Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.
Prabhakaran, Jaya; Underwood, Mark D; Kumar, J S Dileep; Simpson, Norman R; Kassir, Suham A; Bakalian, Mihran J; Mann, J John; Arango, Victoria.
Bioorg Med Chem Lett
; 25(18): 3933-6, 2015 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-26253634
In vivo evaluation of [<sup>18</sup>F]FECIMBI-36, an agonist 5-HT<sub>2A/2C</sub> receptor PET radioligand in nonhuman primate.
Convergent <sup>18</sup>F-labeling and evaluation of N-benzyl-phenethylamines as 5-HT<sub>2A</sub> receptor PET ligands.
Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT<sub>2C</sub> Agonists.
Identification of Optically Active Pyrimidine Derivatives as Selective 5-HT<sub>2C</sub> Modulators.
Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor.
Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.
Alpha-ethyltryptamines as dual dopamine-serotonin releasers.
Design and Discovery of Functionally Selective Serotonin 2C (5-HT<sub>2C</sub>) Receptor Agonists.
Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT<sub>2A</sub> receptor agonists [<sup>18</sup> F]Cimbi-92 and [<sup>18</sup> F]Cimbi-150.
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.